Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-cell receptor (TCR) recognizing Mucor racemosus-derived peptides is a specialized immune receptor found on the surface of T-lymphocytes that specifically identifies antigenic fragments from the Mucorales order of fungi. These receptors play a critical role in the adaptive immune response by binding to fungal peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells. Upon recognition, the TCR triggers T-cell activation, leading to the proliferation of fungus-specific effector cells and the secretion of pro-inflammatory cytokines like interferon-gamma and IL-17, which are essential for controlling invasive fungal growth. In the context of disease, these TCRs are vital for defense against mucormycosis, a life-threatening infection that primarily affects immunocompromised individuals, such as those undergoing hematopoietic stem cell transplantation or chemotherapy. Research into these specific receptors is driving the development of adoptive T-cell therapies, where T-cells are enriched or engineered to express these TCRs to restore antifungal immunity in vulnerable patients. While promising, therapeutic application requires careful monitoring for potential complications such as graft-versus-host disease or excessive inflammatory responses.
Adoptive transfer of T-cells engineered with specific T-cell receptors to recognize and eliminate fungal pathogens through direct cytotoxicity and cytokine-mediated immune coordination.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor recognizing Mucor racemosus-derived peptides (Mucor-specific TCR).